AZTR Stock Forecast: Azitra, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$0.52

The median 12-month analyst price target for Azitra, Inc. is $3.5. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 26 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$3.1M
Ticker Nerd rank
26/ 100
Median analyst target
$3.50
Analysts covering
1
Revenue$0.0
Operating income−$3.4M
Net income−$3.3M
Free cash flow−$3.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Azitra, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
26/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
68
Issuance
45
Revisions
42
Volatility
34
Momentum
32
Growth
26
Quality
14
Value
11

Accruals (68): Reported profit is backed by cash, and the company is not expanding recklessly.

Value (11): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

AZTR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AZTR, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says1 analysts
1
Buy
0
Hold
0
Sell
$3.00
Low
$3.50
Median
$4.00
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
24 Sept 2025Maxim GroupMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for AZTR.

Market Radar

This page is one stock. Monday covers all of them.

AZTR appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Estimates

AZTR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
—
Price / book
0.7×

Cheaper than 80% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−373.2%

Higher than 4% of US stocks

Return on assets
−151.9%

Higher than 1% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Azitra, Inc. has a market value of $3.1M.

  • Revenue in the twelve months to 30 June 2026: $0.0.

  • Net income over the same four quarters: −$12.3M.

  • Free cash flow in the twelve months to 30 June 2026: −$11.4M, after $212K of capital spending.

  • Shares outstanding: 16.2M.

  • Azitra, Inc. employs 13 people.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

AZTR and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
AZTRAzitra, Inc.$3.1M26
SKYESkye Bioscience, Inc.$3.1M50
NRSNNeurosense Therapeutics Ltd.$3.2M3
KPRXKiora Pharmaceuticals, Inc.$3.2M60
CELZCreative Medical Technology Holdings, Inc.$3.1M16
JAGXJaguar Health, Inc.$3.0M50
APREAprea Therapeutics, Inc.$3.2M20

Take a look at AZTR’s peer groups, ranked by the model: healthcare stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Azitra, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about AZTR

What is the AZTR stock price forecast for 2026-2027?

The median 12-month analyst price target for Azitra, Inc. is $3.5, with estimates ranging from $3 to $4. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AZTR stock a buy right now?

Of the 1 analyst covering Azitra, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Azitra, Inc. 26 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AZTR?

As at 21 Nov 2026, Azitra, Inc. ranks 26 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (68 of 100).

Will AZTR stock go up?

No one can know that. What the data says: the median 12-month target from 1 analyst is $3.5, and Ticker Nerd's factor model ranks Azitra, Inc. 26 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AZTR stock forecast for 2030?

No analyst covering Azitra, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AZTR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3 to $4 over the next 12 months.

What does Azitra, Inc. do?

Azitra Inc. is a clinical-stage biopharmaceutical company focused on precision dermatology. The company develops topical live biotherapeutic products and engineered protein-based therapeutics designed to address skin diseases by working with the skin microbiome.

Company

About Azitra, Inc.

Azitra Inc. is a clinical-stage biopharmaceutical company focused on precision dermatology. The company develops topical live biotherapeutic products and engineered protein-based therapeutics designed to address skin diseases by working with the skin microbiome. Its platform combines synthetic biology, microbial engineering, and protein design to create treatments for dermatologic conditions, including rare and hard-to-treat disorders. Azitra Inc. also uses a proprietary microbial library and data-driven screening tools to identify bacterial strains with therapeutic potential. The company’s current product portfolio includes investigational candidates aimed at dermatology and skin-barrier disorders, positioning Azitra Inc. within the specialized market for microbiome-based skin treatments and targeted dermatologic therapeutics.

CEO Mr. Francisco D. Salva · 13 employees · United States · https://azitrainc.com